Long-term efficacy and safety of lamotrigine for all types of bipolar disorder

References

• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th ed DSM-5Arlington, TexasAmerican Psychiatric Publishing2013
   Google Scholar
• MerikangasKRJinRHeJPPrevalence and correlates of bipolar spectrum disorder in the world mental health survey initiativeArch Gen Psychiatry201168324125121383262
   PubMed Web of Science ®Google Scholar
• EtainBLajnefMBellivierFClinical expression of bipolar disorder type I as a function of age and polarity at onset: convergent findings in samples from France and the United StatesJ Clin Psychiatry2012734561566
   PubMedGoogle Scholar
• TondoLBaldessariniRJVázquezGLepriBVisioliCClinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disordersActa Psychiatr Scand2013127535536423121222
   PubMed Web of Science ®Google Scholar
• UndurragaJBaldessariniRJValentíMBipolar depression: clinical correlates of receiving antidepressantsJ Affect Disord20121391899322406337
   PubMed Web of Science ®Google Scholar
• BaldessariniRJLeahyLArconaSGauseDZhangWHennenJPatterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disordersPsychiatr Serv2007581859117215417
   PubMed Web of Science ®Google Scholar
• BaldessariniRHenkHSklarAChangJLeahyLPsychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherencePsychiatr Serv200859101175118318832504
   PubMed Web of Science ®Google Scholar
• SussmanMFriedmanMKornJRHassanMKimJMenzinJThe relationship between use of antidepressants and resource utilization among patients with manic or mixed bipolar disorder episodes: findings from a managed care settingJ Affect Disord2012138342543222326843
   PubMed Web of Science ®Google Scholar
• AltshulerLLPostRMLeverichGSMikalauskasKRosoffAAckermanLAntidepressant-induced mania and cycle acceleration: a controversy revisitedAm J Psychiatry19951528113011387625459
   PubMed Web of Science ®Google Scholar
• GhaemiSNWingoAPFilkowskiMABaldessariniRJLong-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risksActa Psychiatr Scand2008118534735618727689
   PubMed Web of Science ®Google Scholar
• ValentíMPacchiarottiIUndurragaJRisk factors for rapid cycling in bipolar disorderBipolar Disord201517554955925682854
   PubMed Web of Science ®Google Scholar
• PavlovaBPerlisRHAldaMUherRLifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysisLancet Psychiatry20152871071726249302
   PubMed Web of Science ®Google Scholar
• PostRMLeverichGSAltshulerLLRelationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatientsJ Clin Psychiatry201273792493022480597
   PubMed Web of Science ®Google Scholar
• PompiliMVenturiniPPalermoMMood disorders medications: predictors of nonadherence – review of the current literatureExpert Rev Neurother201313780982523898852
   PubMed Web of Science ®Google Scholar
• MurruAPacchiarottiINivoliAMRates and clinical correlates of treatment non-adherence in schizoaffective bipolar patientsActa Psychiatr Scand2012125541241822321052
   PubMed Web of Science ®Google Scholar
• MontesJMMaurinoJde DiosCMedinaESuboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioningPatient Prefer Adherence20137899423378745
   PubMed Web of Science ®Google Scholar
• ReidJGGitlinMJAltshulerLLLamotrigine in psychiatric disordersJ Clin Psychiatry201374767568423945444
   PubMed Web of Science ®Google Scholar
• WeislerRHCalabreseJRBowdenCLAscherJADeVeaugh-GeissJEvoniukGDiscovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistenceJ Affect Disord20081081–21918001843
   PubMed Web of Science ®Google Scholar
• GoodwinGMBowdenCLCalabreseJRA pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorderJ Clin Psychiatry200465343244115096085
   PubMed Web of Science ®Google Scholar
• KoyamaTHiguchiTYamawakiNStudy SCA 104779, an evaluation of BW430C (lamotrigine) versus placebo in the prevention of mood episodes in bipolar I disorder patientsJapanese J Clin Psychiatry2011403369383 Japanese
   Google Scholar
• CalabreseJRSullivanJRBowdenCLRash in multicenter trials of lamotrigine in mood disorders: clinical relevance and managementJ Clin Psychiatry200263111012101912444815
   PubMed Web of Science ®Google Scholar
• MockenhauptMMessenheimerJTennisPSchlingmannJRisk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepilepticsNeurology20056471134113815824335
   PubMed Web of Science ®Google Scholar
• MiuraTNomaHFurukawaTAComparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysisLancet Psychiatry20141535135926360999
   PubMed Web of Science ®Google Scholar
• MimuraCMurashigeMOdaTWatanabeYDevelopment and psychometric evaluation of a Japanese scale to assess depression severity: himorogi self-rating depression scaleInt J Psychiatry Clin Pract2011151505522122689
   PubMed Web of Science ®Google Scholar
• MimuraCNishiokaMSatoNHasegawaRHorikoshiRWatanabeYA Japanese scale to assess anxiety severity: development and psychometric evaluationInt J Psychiatry Med2011411294521495520
   PubMed Web of Science ®Google Scholar
• GuyWECDEU assessment manual fro psychopharmacology: publication ADM 76-338. Clinical Global Impressions (CGI) ScaleWashington, DCDepartment of Health, Education, and Welfare1976218222
   Google Scholar
• HamiltonMThe assessment of anxiety states by ratingBr J Med Psychol1959321505513638508
   PubMed Web of Science ®Google Scholar
• WilliamsJBA structured interview guide for hamilton depression rating scaleArchi Gen Psychiatry1988458742747
   PubMed Web of Science ®Google Scholar
• LinEHVon KorffMKatonWThe role of the primary care physician in patients’ adherence to antidepressant therapyMed Care199533167747823648
   PubMed Web of Science ®Google Scholar
• BusnerJTargumSDThe clinical global impressions scale: applying a research tool in clinical practicePsychiatry (Edgmont)2007472837
   PubMedGoogle Scholar
• SpielmansGIMcFallJPA comparative meta-analysis of Clinical Global Impressions change in antidepressant trialsJ Nerv Ment Dis20061941184585217102709
   PubMed Web of Science ®Google Scholar
• LeuchtSEngelRRThe relative sensitivity of the clinical global impressions scale and the brief psychiatric rating scale in antipsychotic drug trialsNeuropsychopharmacology200631240641216123745
   PubMed Web of Science ®Google Scholar
• ZaiderTIHeimbergRGFrescoDMSchneierFRLiebowitzMREvaluation of the clinical global impression scale among individuals with social anxiety disorderPsychol Med200333461162212785463
   PubMed Web of Science ®Google Scholar
• SeoHJChiesaALeeSJSafety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implicationsClin Neuropharmacol2011341394721242744
   PubMed Web of Science ®Google Scholar
• GrandeIBalanzá-MartínezVJiménez-ArrieroMSIN-DEPRES GroupClinical factors leading to lamotrigine prescription in bipolar outpatients: subanalysis of the SIN-DEPRES studyJ Affect Disord20121431–310210822842026
   PubMed Web of Science ®Google Scholar
• BaldessariniRJTondoLFlorisGHennenJEffects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patientsJ Affect Disord2000611–2132211099736
   PubMed Web of Science ®Google Scholar
• BauerMBeaulieuSDunnerDLLaferBKupkaRRapid cycling bipolar disorder–diagnostic conceptsBipolar Disord2008101 Pt 215316218199234
   PubMed Web of Science ®Google Scholar
• CalabreseJRSheltonMDRapportDJKujawaMKimmelSECabanSCurrent research on rapid cycling bipolar disorder and its treatmentJ Affect Disord2001671–324125511869774
   PubMed Web of Science ®Google Scholar
• El-MallakhRSGaoYJeannie RobertsRTardive dysphoria: the role of long term antidepressant use in-inducing chronic depressionMed Hypotheses201176676977321459521
   PubMed Web of Science ®Google Scholar
• El-MallakhRSVöhringerPAOstacherMMAntidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trialJ Affect Disord201518431832126142612
   PubMed Web of Science ®Google Scholar
• JuddLLSchettlerPJAkiskalHSLong-term symptomatic status of bipolar I vs bipolar II disordersInt J Neuropsychopharmacol20036212713712890306
   PubMed Web of Science ®Google Scholar
• KesslerRCChiuWTDemlerOMerikangasKRWaltersEEPrevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey ReplicationArch Gen Psychiatry200562661762715939839
   PubMed Web of Science ®Google Scholar
• KetterTAWangPWChandlerRADermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rashJ Clin Psychiatry200566564264515889953
   PubMed Web of Science ®Google Scholar
• WooYSBahkWMJonDIRash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trialProg Neuropsychopharmacol Biol Psychiatry20093371147115219540298
   PubMed Web of Science ®Google Scholar
• WangXQXiongJXuWHRisk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysisSeizure201525526125645637
   PubMed Web of Science ®Google Scholar
• SlackJMWEssential Developmental Biology3rd edWiley-Blackwell2012
   Google Scholar
• WeberNSFisherJACowanDNNiebuhrDWPsychiatric and general medical conditions comorbid with bipolar disorder in the National Hospital Discharge SurveyPsychiatr Serv201162101152115821969641
   PubMed Web of Science ®Google Scholar